Gallbladder Diseases: Clinical Trials

5 trials for Gallbladder Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Terminated 5
Phase 22Terminated 2

Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
M7824, Placebo, Gemcitabine - Biliary Tract Cancer, Cholangiocarcinoma
Phase 2 / Phase 3TerminatedEMD Serono Research & Development Institute, Inc.3092019-09-202023-11-14
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
capecitabine, gemcitabine hydrochloride, quality-of-life assessment - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 3TerminatedNCIC Clinical Trials Group192008-10-102023-08-04
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
AMT2003 - Gastrointestinal Cancer, Prostate Cancer
Phase 2 / Phase 3TerminatedAuron Healthcare GmbH672006-05-012013-03-20
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
escitalopram oxalate, Placebo - Colorectal Cancer, Depression
Phase 3TerminatedMassachusetts General Hospital242006-03-012012-12-03
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
becatecarin, 5-Fluorouracil Plus Leucovorin - Biliary Tract Cancer
Phase 3TerminatedHelsinn Healthcare SA2482004-09-012009-01-14

Narrower conditions

Gallbladder Neoplasms (5)  ·  Bile Duct Neoplasms (3)  ·  Liver Neoplasms (3)  ·  Biliary Tract Neoplasms (2)  ·  Cholangiocarcinoma (2)  ·  Colonic Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Camurati-Engelmann Syndrome (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Depression (1)

Broader conditions

Biliary Tract Diseases (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Adenocarcinoma (3)  ·  Bile Duct Diseases (3)  ·  Biliary Tract Neoplasms (3)  ·  Carcinoma (3)  ·  Liver Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Colonic Diseases (2)  ·  Endocrine Gland Neoplasms (2)

Interventions

Gemcitabine (2)  ·  Capecitabine (1)  ·  Cisplatin (1)  ·  Escitalopram (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  becatecarin (1)

Sponsors

Auron Healthcare GmbH (1)  ·  EMD Serono Research & Development Institute, Inc. (1)  ·  Helsinn Healthcare SA (1)  ·  Massachusetts General Hospital (1)  ·  NCIC Clinical Trials Group (1)

Countries

Germany (3)  ·  United States (3)  ·  Canada (2)  ·  France (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Bosnia and Herzegovina (1)  ·  Brazil (1)  ·  Chile (1)  ·  China (1)

Top investigators

Afshin Dowlati, MD (1)  ·  Jennifer Knox, MD (1)  ·  Joachim Drevs, PD Dr. Med (1)  ·  William F. Pirl, MD (1)

Results publications

PMID 32461347, PMID 38875119

NIH funding

2019 (1), K23CA115908 (1)